Hey Jane

We welcome today’s Supreme Court decision to grant a stay in Louisiana v FDA. Hey Jane continues to provide access to high quality, safe and effective abortion care. Courts should not interfere with FDA’s expert decisions allowing mifepristone to be prescribed by telehealth—and patients should not have to navigate legal chaos to continue accessing safe, legal medication abortion through Hey Jane. This case is the latest step in an ongoing effort to disrupt access to the gold standard medication abortion regimen—mifepristone and misoprostol—despite decades of scientific evidence and safety reviews. Restricting patients’ options would not make patients safer. The point of baseless litigation like this is to sow confusion and uncertainty for patients seeking time-sensitive care. At Hey Jane, we’ve cared for more than 100,000 patients, and our experience continues to reinforce the strong safety record behind this model of care. Hey Jane exists because patients deserve private, timely, evidence-based health care without unnecessary barriers. We remain unwavering in our commitment to providing safe, compassionate abortion care and meeting patients where they are when they need us.

We’re proud that Hey Jane has filed an amicus brief with the Supreme Court this week, as part of the ongoing Louisiana v. FDA case. As the most-trusted virtual clinic for reproductive and sexual health care, including abortion care, we know firsthand that abortion pills via telehealth are incredibly safe and effective—and an essential part of health care. We also know the far-reaching impact that restricting telehealth access to one of the two drugs used in the most common medication abortion regimen would have for groups that already face disproportionate barriers in access to care. We urge the Supreme Court to follow the science and reverse the Fifth Circuit court’s baseless order. Because at Hey Jane, we believe that everyone deserves safe and supportive access to the highest quality care without unnecessary barriers.

A statement from Hey Jane's Co-Founder and CEO on today's SCOTUS decision.

In an economy obsessed with the price of eggs and gas, women’s health care has become a line item many are being forced to cut. At Hey Jane, we wanted to see the data behind the struggle. In April 2026, we surveyed 700 women (ages 18-44) across the U.S. and the results are clear: Women are skipping doctors' appointments, delaying reproductive health care, and putting off having children—not because they want to, but because they simply can’t afford to. Key takeaways from our findings: • Nearly 1 in 3 women have delayed or reconsidered having children due to economic concerns in the past 12 months. • Nearly 2 in 3 women delayed or skipped at least one health care service in the past 12 months due to cost or financial concerns. • More than half of all women are not confident they could afford an unexpected medical expense in the next 12 months. Just 1 in 10 feel very confident. This isn't a budgeting problem. It’s a systemic barrier that forces women to choose between their financial stability and their physical autonomy. The silver lining? Women are ready for a new model. Our data shows a massive shift toward virtual care as a primary pathway for affordable, accessible reproductive health. See the full findings and learn how we’re working to close the access gap at the link below. https://lnkd.in/gyxNFT3v

We are incredibly proud to see Hey Jane’s Chief Medical Officer, Amy Potter, MD, featured on FOX 11 chatting about why telehealth is becoming such a vital (and safe!) option for so many patients seeking health care. Catch the full segment at the link below. https://lnkd.in/gnvA9qZ9

Today, a federal district court judge has granted the FDA’s request to pause Louisiana’s challenge that would halt the dispensing of mifepristone via telemedicine. It is the latest case to attempt to restrict access to mifepristone. This decision means FDA regulations on mifepristone remain unchanged, allowing abortion-seekers to continue accessing safe, legal medication abortion through virtual clinics like Hey Jane. The facts couldn’t be clearer: Mifepristone is safe, effective, and FDA-approved since 2000.

A common misconception surrounding abortion care is that it’s synonymous with women’s health care, but at Hey Jane, we know that’s only part of the story. The truth? Abortion care is for every body.   On this #TransgenderDayOfVisibility, we celebrate the vibrancy of the transgender community and reaffirm our commitment to providing discreet, accessible, care that sees, respects, and supports you exactly as you are. 🏳️⚧️✨   To learn more about how we can be more inclusive in our conversations about abortions, tap the link below. https://lnkd.in/es2J7xNB

Hey Jane is the go-to virtual clinic for compassionate, evidence-based abortion care—and more. But don’t take our word for it. Read what real patients have to say at heyjane.com/reviews. 

🌟We’re hiring!🌟 Hey Jane is looking for a high-velocity, high-vision Senior Graphic Designer to join our team and help us build the most accessible, trusted virtual abortion clinic. Learn more and apply here: https://lnkd.in/dYbZT_YE

Today, as a federal court in Louisiana hears arguments to restrict nationwide access to medication abortion, we are proud to stand with the ACLU and a broad coalition of medical experts and advocates in this critical fight. We filed an amicus brief in this case to share our patients’ stories and make it clear that telemedicine is a lifeline; it removes the barriers of distance and cost that stand between patients and the safe, effective health care they deserve. To everyone feeling anxious about today’s news: Hey Jane is still here and we are still providing care. Want to help support our work? Share this post, so that we spread the word that care is still available—regardless of the headlines! https://lnkd.in/gR-K4bbi